<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4172">
  <stage>Registered</stage>
  <submitdate>18/11/2013</submitdate>
  <approvaldate>18/11/2013</approvaldate>
  <nctid>NCT01991106</nctid>
  <trial_identification>
    <studytitle>Effects of Exercise Intensity in Obese Children and Adolescents</studytitle>
    <scientifictitle>A Multi-centre Randomized Controlled Trial Examining the Effects of High Intensity Interval Training on Cardio-metabolic Outcomes in Obese Children and Adolescents</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2009/1313</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
  </conditions>
  <interventions>
    <interventions>Behaviour - High intensity interval training
Behaviour - Moderate intensity continuous training
Other interventions - Nutritional advice

Experimental: High intensity interval training - 10-minute warm up at 60-70% of maximal heart rate (HRmax). Then walking, running or cycling at 85-95% of maximal heart rate at intervals of 4 x 4 minutes, with 3 minute active breaks (50-70% of HRmax) between intervals. A 5-minute cool down period.

Experimental: Moderate intensity continuous training - walking, running or cycling continuously at 60-70% HRmax for 44 minutes.

Active Comparator: nutritional advice - 10 individual nutrition consultations with an accredited dietitian over the 12 month period. Content of consultations will include healthy food choices, portion sizes and regular mealtimes.

No Intervention: non-obese children - 100 healthy non-obese children aged 7-16 (controls)


Behaviour: High intensity interval training
Twelve weeks of 2-3 supervised training sessions each week.

Behaviour: Moderate intensity continuous training
Twelve weeks of 2-3 supervised training sessions each week.

Other interventions: Nutritional advice
healthy food choices, portion sizes and regular mealtimes

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Peak systolic tissue velocity - systolic tissue Doppler velocity assessed during resting and stress echocardiography</outcome>
      <timepoint>12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Subcutaneous and total abdominal adipose tissue - Assessed using MRI</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiorespiratory fitness (VO2peak) - Assessed using a maximal treadmill test</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Body composition - Assessed using DXA (UQ), BodPod (NTNU)</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood biochemistry - Analysed for lipids, glucose, insulin, inflammatory makers, satiety hormones, oxidative stress</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical activity - Assessed through 7 day accelerometry</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Dietary analysis - Assessed through a three-day food record</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Myocardial structure and cardiac adipose tissue (UQ) - Assessed through cardiac MRI; participants &gt; 12 years only</outcome>
      <timepoint>12 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Arterial stiffness - Assessed through pulse wave velocity and pulse wave analysis</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Autonomic function - Assessed through heart rate variability and heart rate recovery</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life - Assessed through the Paediatric Quality of Life Inventory</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Visceral adipose tissue - assessed by magnetic resonance imaging (MRI)</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Vascular function - Assessed through flow mediated dilation procedure</outcome>
      <timepoint>12 weeks, 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Peak systolic tissue velocity - systolic tissue Doppler velocity assessed during resting and stress echocardiography</outcome>
      <timepoint>12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Obese (BMI = 95th percentile - age and sex specific criteria)</inclusivecriteria>
    <inclusiveminage>7</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>16</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Elevated blood pressure (= 95th percentile for systolic or diastolic values)

          -  Congenital heart disease

          -  Coronary artery disease

          -  Family history of hypertropic obstructive cardiomyopathy

          -  Any abnormality during rest or stress echocardiography which indicates it would be
             unsafe to participate

          -  Self reported kidney failure

          -  Any major organ transplant

          -  Considerable pulmonary disease including severe or poorly controlled asthma

          -  Smoking

          -  Diabetes

          -  Epilepsy or a history of seizures

          -  Orthopaedic or neurological limitations to exercise

          -  Diagnosed attention deficit hypersensitivity disorder

          -  Steroid medications

          -  Participation in another research study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/11/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>100</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>31/03/2017</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>University of Queensland - Brisbane</hospital>
    <postcode> - Brisbane</postcode>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Trondheim</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Norwegian University of Science and Technology</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of Queensland</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The prevalence of paediatric obesity has increased over the last two decades and with it, an
      increased diagnosis of lifestyle-related diseases in children and adolescents. High intensity
      interval training has recently been explored as an alternate to traditional aerobic exercise
      in adults with chronic disease and has potential to induce rapid reversal of subclinical
      disease markers in obese children and adolescents.

      High intensity interval training has recently been explored as an alternate to traditional
      aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of
      subclinical disease markers in obese children and adolescents.

      Goal: The primary aim of this randomised controlled trial is to evaluate the effectiveness of
      a high intensity interval training intervention on myocardial function, vascular function and
      visceral adipose tissue in obese children and adolescents at baseline, three and twelve
      months.

      Method: Multi-centre randomised controlled trial of 100 obese children and adolescents in the
      cities of Trondheim (Norway) and Brisbane (Australia). Participants will be randomised to (1)
      high intensity interval training, (2) moderate intensity continuous training or (3) nutrition
      advise. Participants will partake in supervised exercise training and/or nutrition
      consultations for 3 months. Measurements for all study endpoints will occur at baseline, 3
      months (post intervention) and 12 months (follow up).

      Scientific Significance : This randomised controlled trial will general substantial
      information regarding the effects of exercise intensity on paediatric obesity, specifically
      the cardio-metabolic health of this at-risk population. It is expected that communication of
      results will allow for more robust and realistic guidelines regarding exercise prescription
      in this population to be formed while outlining the benefits of high intensity interval
      training on subclinical markers of disease.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01991106</trialwebsite>
    <publication>Dias KA, Coombes JS, Green DJ, Gomersall SR, Keating SE, Tjonna AE, Hollekim-Strand SM, Hosseini MS, Ro TB, Haram M, Huuse EM, Davies PS, Cain PA, Leong GM, Ingul CB. Effects of exercise intensity and nutrition advice on myocardial function in obese children and adolescents: a multicentre randomised controlled trial study protocol. BMJ Open. 2016 Apr 4;6(4):e010929. doi: 10.1136/bmjopen-2015-010929.
</publication>
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ulrik Wisl√∏ff, prof</name>
      <address>Norwegian University of Science and Technology</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>